Description: Aziyo Biologics, Inc. operates as a biotechnology company which focuses on regenerative medicine in areas such as cardiology, orthopedics and other medical specialties. It offers cardiac device envelope, vascular surgery, cardiothoracic repair, orthopedics and spine, sports medicine, dermal, and wound care. The company was founded on August 6, 2015 and is headquartered in Silver Spring, MD.
Home Page: www.aziyo.com
AZYO Technical Analysis
12510 Prosperity Drive
Silver Spring,
MD
20904
United States
Phone:
240 247 1170
Officers
| Name | Title |
|---|---|
| Mr. Kevin L. Rakin M.B.A, M.S. | Exec. Chairman |
| Dr. C. Randal Mills Ph.D. | Co-Founder, Pres & CEO and Director |
| Mr. Matthew B. Ferguson | Chief Financial Officer |
| Mr. Thomas Englese | Chief Commercial Officer |
| Ms. Erica Elchin | VP of Global Operations |
| Dr. Michelle LeRoux Williams Ph.D. | Chief Scientific Officer |
| Ms. Courtney Guyer | VP of Marketing |
| Dr. Sonali Fonseca Ph.D. | Head of Emerging Bus.es |
| Mr. Jeffry D. Hamet | Sr. VP of Fin., Treasurer & Sec. |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 13.3419 |
| Price-to-Sales TTM: | 1.2859 |
| IPO Date: | 2020-10-08 |
| Fiscal Year End: | December |
| Full Time Employees: | 166 |